Legal notice

Under Article 6 of Act No. 2004-575 of June 21, 2004 on the Confidence in the Digital Economy, users of the site https://nvdiag-labcom.fr/ are informed of the identity of the various stakeholders in the framework of its implementation and monitoring:

Identity of the site manager

Supported by the Agence Nationale de la Recherche (ANR), NVDIAG—short for Nano-antibody generation using extracellular Vesicles for DIAgnostic purposes—is a collaborative laboratory (LabCom) formed through a bilateral partnership between the Laboratoire d’Ingénierie des Systèmes Macromoléculaires (LISM) and BioCytex, both located in Marseille. The NVDIAG LabCom plays a leading role in advancing innovation in hemato-oncology, focusing on the development of camelid monoclonal antibodies (nano-antibodies) that serve a variety of tests and companion diagnostics solutions.

Address:

LISM, CNRS-UMR 7255
31 chemin Joseph Aiguier – CS 70071
13402 Marseille Cedex 09, France

+33(0)4 91 16 41 24
www.nvdiag-labcom.fr
contact@nvdiag-labcom.fr

Director of publication:

Alain Roussel

Credits

Production & editorial maintenance
KOM Agency

Technical direction
TARABUSK for KOM Agency

Graphic design & illustrations
Hugo Cazin FOR KOM Agency

Photography
Jean-Marie Huron for KOM Agency

Hosting
2switch – https://www.o2switch.fr/ INPI registered trademark: 09 3 645 279 Siret: 510 909 80700024 – RCS Clermont Ferrand SARL with capital of 100,000 € Telecom operator declared ARCEP – Owner of its network AS50474

Privacy policy

The NVDIAG LabCom aims to produce proteins, generate nano-antibodies, and perform structural studies which must meet ethical and regulatory requirements. For more details on how we ensure compliance with these requirements, including the protection of personal data in accordance with the General Data Protection Regulation (GDPR), please consult our Privacy policy.